Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John C London Insider Profile
4 Followers
John C London, Director at Crescita Therpeutc, holds 193.52K shares in Crescita Therpeutc (Ticker: TSE:CTX), holds 155.79K shares in Nuvo Pharmaceuticals (Ticker: TSE:MRV).
John C London has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that John C London holds in companies
Most Profitable Insider Trade
Stock:
Nuvo Pharmaceuticals
(MRV)
(MRV)
Rating:Informative Buy
Date:Apr 03, 2014 - Apr 03, 2015
Return:+57.40%
The most profitable trade made by John C London
John C London's Trading History
Crescita Therpeutc
Mar 19, 2018
Director
Uninformative Sell
―
C$96.76K
Nuvo Pharmaceuticals
Mar 07, 2016
―
Uninformative Buy
―
C$209.53K
List of latest transactions for each holding click on a transaction to see John C London's performance on stock
You May Also Like
John C London insider profile FAQ
What is the percentage of profitable transactions made by John C London?
The percentage of profitable transactions made by John C London is ―.
What is the average return per transaction made by John C London?
The average return per transaction made by John C London is ―.
What stocks does John C London hold?
John C London holds: TSE:CTX, TSE:MRV stocks.
What was John C London’s latest transaction?
John C London latest transaction was an Uninformative Sell of ―.
What was John C London's most profitable transaction?
John C London’s most profitable transaction was an Informative Buy of TSE:MRV stock on April 3, 2014. The return on the trade was 57.40%.
What is John C London's role in Crescita Therpeutc?
John C London's role in Crescita Therpeutc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.